| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8232635 | International Journal of Radiation Oncology*Biology*Physics | 2010 | 8 Pages |
Abstract
As compared with chemotherapy alone, adjuvant treatment with both radiotherapy and chemotherapy improves survival in patients with completely resected Stage III-N2 nodal disease in NSCLC. Future study of treatment modality with radiotherapy and chemotherapy is warranted, especially focusing on both N1 and N2 nodal status.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Bingwen M.D., Yong M.D., Tao M.D., Wenhui M.D., Bangxian M.D., Lin M.D., Lu M.D., Yongmei M.D., Jiang M.D., Meijuan M.D., Jin M.D., Li M.D., Youlin M.D., Guowei M.D., Lunxu M.D., Mei M.D., You M.D.,